Description
Human NCI-H1650 is a human cancer cell line derived from a patient with non-small cell lung cancer (NSCLC), from 27-year-old male with bronchoalveolar carcinoma. It is an adherent cell line with epithelial-like morphology. NCI-H1650 is extensively used in cancer research to understand the biological mechanisms and pathways involved in lung adenocarcinoma.
This RFP / human NCI-H1650 cell line expresses the codon-optimized monomer RFP fluorescent reporter, under the enhanced super CMV (suCMV) Promoter. Cell line carries the Puromycin resistance.
The following expression cassette was integrated into the cell line’s genome:
Each cell showed RFP fluorescent signal. see a sample image below:
Sold at: 1 vial x (2 x 106 cells)/vial, see details in Product Manual.
Cat# SC098-R
